🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: fluticasone furoate (FF)

Found 99 matching trials

A Study to Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.

PHASE1

This study will assess the saftey of giving fluticasone furoate 200mcg/GW64...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-11-18

Trial ID

NCT01266980

Treatments Being Tested

Inhaled FF/ GW642444M (200/25mcg)

To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI)

PHASE1

This will be a randomized, double-blind, single-dose, three-period balanced...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-11-08

Trial ID

NCT01725685

Treatments Being Tested

FF 400 mcg UMEC 500 mcg FF/UMEC 400/500 mcg

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

PHASE2

This is a randomized, placebo-controlled, 2-period crossover, escalating re...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-02-09

Trial ID

NCT02991859

Treatments Being Tested

Fluticasone furoate (FF) Dry Powder Inhaler Fluticasone propionate (FP) Dry Powder Inhaler Budesonide (BUD) Turbuhaler Placebo (ELLIPTA or DISKUS)

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

PHASE2

The purpose of the study is to determine the appropriate dose of fluticason...

Status

Completed

Location

Research Site

Start Date

2006-11

Trial ID

NCT00403286

Treatments Being Tested

Fluticasone Propionate/Formoterol Fumarate Fluticasone Propionate/Formoterol Fumarate Fluticasone Propionate/Formoterol Fumarate Fluticasone Propionate/Formoterol Fumarate Fluticasone Propionate Formoterol Fumarate Fluticasone Propionate/Salmeterol Xinafoate Placebo

Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation

PHASE1

This is an open-label, five- period, cross-over, randomized, single dose, s...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-10-28

Trial ID

NCT02218723

Treatments Being Tested

FF UD-DPI FF ELLIPTA DPI

Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response

PHASE2

We propose to use an inhaled allergen challenge model to explore the indivi...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-05

Trial ID

NCT01128595

Treatments Being Tested

FF/GW642444M GW642444M Fluticasone Furoate Placebo

Intranasal Steroids and Oxymetazoline in Allergic Rhinitis

PHASE4

We hypothesize that once daily use of oxymetazoline will not cause signific...

Status

Completed

Location

University of Chicago

Start Date

2007-06

Trial ID

NCT00584987

Treatments Being Tested

Fluticasone furoate Placebo Fluticasone furoate Oxymetazoline Placebo Oxymetazoline

A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment.

PHASE1

In relation to their severity, hepatic diseases can significantly modify dr...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-10-18

Trial ID

NCT01266941

Treatments Being Tested

Inhaled FF 200mcg/GW642444M 25mcg

Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses

PHASE1

This study will evaluate the pharmacokinetics of FF, UMEC and VI administer...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-07-15

Trial ID

NCT01894386

Treatments Being Tested

FF 400 mcg UMEC 500 mcg UMEC 250 mcg VI 100 mcg

Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms

PHASE4

People who have hayfever or allergic rhinitis often complain about eye symp...

Status

Completed

Location

The University of Chicago

Start Date

2009-11

Trial ID

NCT01007253

Treatments Being Tested

PL nasal spray fluticasone furoate (FF)PL eye drops olopatadine (OLO)

Previous Next